Home • About • Security Advisory for Axeda Access:7 vulnerabilities Security Advisory for Axeda Access:7 vulnerabilities LBS Product Security Product Security Overview Product Security Advisories Report A Security Vulnerability 2022 April 6 (last updated 2022 May 6) CVE-2022-25246, CVE-2022-25247, CVE-2022-25248, CVE-2022-25249, CVE-2022-25250, CVE-2022-25251, CVE-2022-25252 Background Leica Biosystems has been notified of 7 vulnerabilities associated with a remote access solution produced by Axeda, collectively known as Access:7. In 2014 PTC acquired Axeda and the Axeda software was later phased out by the end of 2020. Leica Biosystems has reviewed our products and identified a Leica Biosystems service that impacts multiple Leica Biosystems products. The service was called RemoteCare and is no longer distributed or supported. RemoteCare used part of the Axeda software containing some of the vulnerabilities listed in Access:7. When RemoteCare service was discontinued on 31st December 2020, the Axeda software was no longer necessary, however in some circumstances it may not have been removed or disabled completely. Where the software remained, the product could be at risk. Product Status Product Status Regarding Access:7 Recommendations and Comments Aperio AT2 (DX) Not Vulnerable Axeda software is not present. Aperio CS2 Not Vulnerable Axeda software is not present. Aperio eSlide Manager Not Vulnerable Axeda software is not present. Aperio GT 450 (DX) Not Vulnerable Axeda software is not present. Aperio ImageScope (DX) Not Vulnerable Axeda software is not present. Aperio LV1 Not Vulnerable Axeda software is not present. Aperio Scanner Administration Manager (SAM) Server for GT 450 (DX) Not Vulnerable Axeda software is not present. Aperio VERSA Not Vulnerable Axeda software is not present. Aperio WebViewer DX Not Vulnerable Axeda software is not present. BOND-ADVANCE, BOND Controller Potentially Vulnerable Axeda software used by RemoteCare was not preinstalled by default. Only customers who purchased the RemoteCare service and had the Axeda software installed on the BOND Controller are impacted. If you have not previously purchased the RemoteCare service, then you are not vulnerable, and no further action is necessary. If you have previously purchased RemoteCare, then there is a possibility that the Axeda software could still be on the system and active. If this is the case, then your BOND instrument could be vulnerable to malicious persons or malware with access to the same network the BOND instrument is connected to. Customers with firewalls or other network protections in place to limit access to the BOND instrument may have significantly reduced the risk of this vulnerability. Leica Biosystems will remove the Axeda software and RemoteCare during the next maintenance visit for customers who have the software installed. Customers who have assessed and found their network protections do not sufficiently mitigate the risk are encouraged to contact a local Leica Biosystems representative as a matter of priority. Customers who do not have a Service Agreement with Leica Biosystems should also contact a local Leica Biosystems representative. BOND-III Not Vulnerable Axeda software is not present. BOND-MAX Not Vulnerable Axeda software is not present. BOND RX, BOND RXm Not Vulnerable Axeda software is not present. CEREBRO Potentially Vulnerable Axeda software used by RemoteCare was not preinstalled by default. Only customers who opted to use RemoteCare service instead of using their own remote support solution had the Axeda software installed on the CEREBRO server and workstations. If you have not opted to use the RemoteCare service for remote support, then you are not vulnerable, and no further action is necessary. If you are not sure, you can contact a local Leica Biosystems service center to have a Leica representative check if RemoteCare has been installed or not. If you have RemoteCare installed, then there is a possibility that the Axeda software could still be active on the system. If this is the case, then your CERBRO system could be vulnerable to malicious persons or malware with access to the same network the CEREBRO system is connected to. Customers with firewalls or other network protections in place to limit access to the CEREBRO system may have significantly reduced the risk of this vulnerability. For the customers who have the RemoteCare software installed, Leica Biosystems will remove the software using remote access if available or during the next maintenance visit. Customers who have assessed and found their network protections do not sufficiently mitigate the risk are encouraged to contact a local Leica Biosystems representative as a matter of priority. Customers who do not have a Service Agreement with Leica Biosystems should also contact a local Leica Biosystems representative. CytoVision Not Vulnerable Axeda software is not present. HistoCore Arcadia C Not Vulnerable Axeda software is not present. HistoCore Arcadia H Not Vulnerable Axeda software is not present. HistoCore PEARL Potentially Vulnerable The Axeda software used in RemoteCare is installed but disabled by default. If you have previously purchased RemoteCare, then the Axeda software will have been enabled, in which case your system could be vulnerable to malicious persons or malware with access to the same network the instrument is connected to. To protect against this vulnerability Leica Biosystems advises customers to remove and discard the network cable if one is connected to the instrument. HistoCore PEGASUS (PLUS) Not Vulnerable Axeda software is not present. HistoCore PELORIS 3 Potentially Vulnerable Axeda software used by RemoteCare was not preinstalled by default. If you have previously purchased RemoteCare, then the Axeda software will have been installed and enabled, in which case your system could be vulnerable to malicious persons or malware with access to the same network the instrument is connected to. Customers who do not have their instrument connected to a network will not be at risk even if they have purchased RemoteCare previously. Leica Biosystems will remove the Axeda software and RemoteCare during the next maintenance visit for customers who have the software installed. Customers may protect against this vulnerability in the interim by removing and discarding the network cable if one is connected to the instrument. Customers who do not have a Service Agreement with Leica Biosystems may also contact a local Leica Biosystems representative to have the software removed. HistoCore SPECTRA CV Not Vulnerable Axeda software is not present. HistoCore SPECTRA ST Potentially Vulnerable The Axeda software used in RemoteCare is installed and enabled by default even when RemoteCare was not purchased. Customers who do not have their instrument connected to a network will not be at risk. Customers who have the instrument connected to a network may be vulnerable to malicious persons or malware with access to the same network the instrument is connected to. To protect against this vulnerability Leica Biosystems advises customers to remove and discard the network cable if one is connected to the instrument. HistoCore SPIRIT ST Not Vulnerable Axeda software is not present. HistoCore SPRING ST Not Vulnerable Axeda software is not present. Leica ASP200 (S), Leica ASP300 (S) Potentially Vulnerable The Axeda software used in RemoteCare is installed and enabled by default even when RemoteCare was not purchased. Customers who do not have their instrument connected to a network will not be at risk. Customers who have the instrument connected to a network may be vulnerable to malicious persons or malware with access to the same network the instrument is connected to. To protect against this vulnerability Leica Biosystems advises customers to remove and discard the network cable if one is connected to the instrument. Leica ASP6025 (S) Potentially Vulnerable The Axeda software used in RemoteCare is installed and enabled by default even when RemoteCare was not purchased. Customers who do not have their instrument connected to a network will not be at risk. Customers who have the instrument connected to a network may be vulnerable to malicious persons or malware with access to the same network the instrument is connected to. To protect against this vulnerability Leica Biosystems advises customers to remove and discard the network cable if one is connected to the instrument. Leica CV5030 Not Vulnerable Axeda software is not present. Leica IP C Not Vulnerable Axeda software is not present. Leica IP S Not Vulnerable Axeda software is not present. Leica ST4020 Not Vulnerable Axeda software is not present. Leica ST5010 Not Vulnerable Axeda software is not present. Leica ST5020 Not Vulnerable Axeda software is not present. Leica TP1020 Not Vulnerable Axeda software is not present. PELORIS, PELORIS II Potentially Vulnerable The Axeda software used in RemoteCare is installed but disabled by default. If you have previously purchased RemoteCare, then the Axeda software will have been enabled, in which case your system could be vulnerable to malicious persons or malware with access to the same network the instrument is connected to. Customers who do not have their instrument connected to a network will not be at risk even if they have purchased RemoteCare previously. Leica Biosystems will remove the Axeda software and RemoteCare during the next maintenance visit for customers who have the software installed. Customers may protect against this vulnerability in the interim by removing and discarding the network cable if one is connected to the instrument. Customers who do not have a Service Agreement with Leica Biosystems may also contact a local Leica Biosystems representative to have the software removed. LIS Connect Not Vulnerable Axeda software is not present. PathDX Not Vulnerable Axeda software is not present. ThermoBrite Elite Not Vulnerable Axeda software is not present. Disclaimer The information on this site is based on information Leica Biosystems has been able to gather as of the date of this update. The information is intended to help customers address the situation described herein. Leica Biosystems evaluates risk based on common use of our devices or systems, and our evaluation may not represent the actual risk to your local installation and individual environment. It is recommended that all users determine the applicability of this information to their individual environments and take appropriate actions. This information is provided "as is" and does not offer or imply any kind of guarantee or warranty. Leica Biosystems expressly disclaims all warranties, either express or implied, including the warranties of merchantability and fitness for a particular purpose. In no event shall Leica Biosystems or its affiliates be liable for any damages whatsoever arising from or related to the information contained herein or actions that you decide to take based thereon, including any direct, indirect, incidental, consequential, loss of business profits or special damages, even if Leica Biosystems or its affiliates have been advised of the possibility of such damages. Your use of the information on the document is at your own risk. Leica Biosystems reserves the right to change or update this document at any time.
